Motherisk Update: Safety of gadolinium during pregnancy

Facundo Garcia-Bournissen, Alon Shrim, Gideon Koren

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Abstract

Question: A pregnant patient who underwent magnetic resonance imaging (MRI) because of an acute abdomen, was told that MRI contrast agents (ie, gadolinium-based contrast agents) are contraindicated during pregnancy. What is the risk to her baby? Answer: Current radiology practices and recommendations discourage the use of gadolinium-based contrast agents during pregnancy because their safety for the fetus has not yet been proven. In line, however, with the European Society of Radiology guidelines and based on the available evidence, gadolinium-based contrast agents appear to be safe in pregnancy. Gadolinium use should be considered when the diagnostic study is important for the health of the mother.

Original languageEnglish
Pages (from-to)309-310
Number of pages2
JournalCanadian Family Physician
Volume52
Issue numberMAR.
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Motherisk Update: Safety of gadolinium during pregnancy'. Together they form a unique fingerprint.

Cite this